Using the enhanced liver fibrosis test to identify disease in at-risk populations - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Employing the enhanced liver fibrosis assessment to detect disease in high-risk groups

  • By

  • Alex Hinkson

  • Jacob Feathers

  • Jason Punnamkuzhy

  • Firuza Dzhakangirli

  • Ian Alston Rowe

  • Richard Parker

  • May 5, 2026

Share

Original Source(s)

Using the enhanced liver fibrosis test to identify disease in at-risk populations

  • by Alex Hinkson, Jacob Feathers, Jason Punnamkuzhy, Firuza Dzhakangirli, Ian Alston Rowe, Richard Parker

  • May 5, 2026

Related Content

Evaluation of Serum Farnesoid X Receptor (FXR) Levels and Their Correlation with Metabolic Parameters Related to Obesity: A Clinical Investigation

Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine

Risk factors for inferior right hepatic vein occlusion following right lobe living donor liver transplantation: a single-center experience with 240 cases